College of American Pathologists

About CAP Career Center Contact Us		Search:
			[Advanced Search]

CAP Reference Resources and Publications

CAP Accreditation and Laboratory Improvement

CAP Home > CAP Learning Portal > Pharmacogenomics

Pharmacogenomics - From Concepts to Cases

Pharmacogenomics: From Concepts to Cases Series

The integration of diagnostics and therapeutics through pharmacogenomics is a major growth opportunity for practicing pathologists to impact personalized medicine.

Already, new molecular techniques are rapidly reshaping clinical laboratories and the diagnostics they deliver.

CAP’s newest learning resource— Pharmacogenomics— is the pathologist’s opportunity to lead this emerging field and become more involved in the patient care team.

COURSE OBJECTIVES

Understand and apply the principles of pharmacology and molecular testing
Identify opportunities to improve drug therapy via the detection of specific genetic variants
Evaluate and select the laboratory instruments, kits, and procedures for genomic- and molecular-level diagnostics
Guide clinical teams and patients in the choice of screenings and targeted treatments
Advise and monitor dosing, sensitivity, and patient outcomes

The Pharmacogenomics: From Concepts to Cases Series includes the following two programs:

The Pharmacogenomics Essentials Program—Four online courses combine to provide a comprehensive understanding of key genetic and pharmacologic principles that underlie this emerging science.

Pharmacogenomics Essentials Program	CME/SAM/CE credits	Availability
Basic Concepts in Genetics—review genetic principles to establish the foundation for understanding molecular diagnostic testing	2	September 2012
Pharmacokinetics & Pharmacodynamics Underlying Pharmacogenomic Testing—explore these key concepts underlying the molecular study of genetic factors as they impact drug efficacy and toxicity	2	September 2012
Methods for Pharmacogenomic Testing and Clinical Applications—understand the techniques and technologies in the context of their clinical applications in drug metabolism and cancer and how to ensure quality molecular test results	2.5	September 2012
Pharmacogenomics in Medical Practice—apply the concepts and principles of molecular testing and pharmacology to impact patient care	3.5	January 2013

The Pharmacogenomics Applied Program—
Through a series of in-depth online case studies, participants review established scientific data, probe efficacy issues, and learn the latest developments across a range of diseases and therapies—from oncology to infectious disease.

Pharmacogenomics Applied Program	CME/SAM/CE Credits	Availability
Regulatory Compliance—apply regulatory and accreditation requirements for FDA-cleared and laboratory-developed pharmacogenomic tests	1	February 2013
*HLA-B5701**—correlate this allele’s association with abacavir hypersensitivity	1	Q2 2013
Colon Cancer—evaluate the impact of EGFR/KRAS results on diagnosis and treatment	1	Q3 2013
Lung Cancer—evaluate the impact of EGFR/KRAS results on diagnosis and treatment	1	Q1 2014
Melanoma—correlate BRAF screening results with implications for targeted therapy and patient outcomes	1	Q2 2014
Next-Generation Sequencing—review the clinical implications of next generation sequencing and apply the appropriate laboratory accreditation requirements to improve the diagnosis and treatment of patients	1	Q3 2014

Pricing/Registration

Pharmacogenomics Component	CAP Member	Non-Member	Residents
Concepts to Cases Series complete series includes both programs, Essentials + Applied 10 activities (Courses + Case Studies)	$800	$960	$400
Essentials Program 4 Courses	$600	$700	$250
Applied Program 6 Case Studies	$360	$420	$150